Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lidocaine + menthol is a combination topical medication used for the temporary relief of pain and itching associated with minor burns, sunburns, minor cuts and scrapes, insect bites, muscle and joint aches or other minor skin irritations. Lidocaine acts as a local anesthetic by blocking sodium channels in neuronal cell membranes (Sodium channel protein type 1 subunit alpha), thereby reducing nerve signal transmission and numbing the area. Menthol provides a cooling sensation by activating cold-sensitive TRPM8 receptors on sensory nerves and also has mild local analgesic effects. This combination is available over-the-counter in various formulations such as gels or patches[1][3][4][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + menthol.